Your session is about to expire
← Back to Search
Chemotherapy +/− Radiation for Kidney Cancer
Study Summary
This trial is studying whether giving vincristine, dactinomycin, and doxorubicin with or without radiation therapy or observation only is effective in treating patients with Wilms' tumor.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA rubber-stamped doxorubicin hydrochloride for public use?
"Doxorubicin hydrochloride is considered safe according to our team's 3-point scale. This medication has progressed to Phase 3 clinical trials, meaning that there is both efficacy and safety data available."
Can you tell me about other experiments that have used doxorubicin hydrochloride?
"Doxorubicin hydrochloride was first studied in 1997 at the Spectrum Health Hospital - Butterworth Campus. So far, 904 completed studies have been conducted. Additionally, 479 clinical trials are actively recruiting patients as of now. Many of these trials are based in Indianapolis, Indiana."
Does this trial explore novel territory?
"479 clinical trials using doxorubicin hydrochloride are currently underway in 2088 cities and 69 countries. The first trial began in 1997, 300 participants were enrolled, and it completed Phase 3 drug approval in 1997. Since then, 904 similar studies have been completed."
What are some of the more common treatments that doxorubicin hydrochloride is used for?
"Doxorubicin hydrochloride is a medication used to treat several conditions, the most common being malignant neoplasm of testis. It can also be effective in treating Kaposi's sarcoma AIDS related, neoplasm metastasis, and acquired immunodeficiency syndrome."
Share this study with friends
Copy Link
Messenger